Karim Benali1,2, Van Duc Lai3,4, Nefissa Hammache3,4, Isabelle Magnin-Poull3,4, Christian de Chillou3,4, Jean-Marc Sellal3,4. 1. Department of Cardiology, CHU de Saint-Etienne, 42270, Saint-Priest-En-Jarez, France. mirakbenali@gmail.com. 2. INSERM-IADI, U1254, F-54500, Vandœuvre lès-Nancy, France. mirakbenali@gmail.com. 3. INSERM-IADI, U1254, F-54500, Vandœuvre lès-Nancy, France. 4. Department of Cardiology, CHRU de Nancy, 54500, Vandœuvre lès-Nancy, France.
Abstract
BACKGROUND: Pulmonary vein (PV) isolation (PVI) has become the cornerstone of atrial fibrillation (AF) ablation in patients with paroxysmal AF (PAF). PVI durability is influenced by many factors including PVs anatomy. Data regarding the influence of PVs anatomical variations on the outcomes of PAF ablation in the era of contact force-sensing ablation catheters are scarce and contradictory. METHODS: Consecutive patients referred to our center for a first ablation of PAF using radiofrequency (RF) were included. PVs anatomy was classified into 3 groups: typical anatomy (4 distinct veins), left common ostium (LCO), and right accessory PV (RAPV). The primary outcome was recurrence of atrial arrhythmia episode during a 12-month follow-up after ablation. RESULTS: Two hundred twenty-three patients were included (mean age 58.4 ± 10.8 years and 70.9% male). Among this cohort, 141 patients (63.2%) had typical PV anatomy, 53 (23.8%) had a LCO, and 29 (13.0%) had a RAPV. The existence of a RAPV was not associated with a higher rate of AF recurrences (22 (14.3%) vs. 7 (10.1%), p = 0.519). After multivariate analysis, the presence of an LCO did not appear to be associated with the AF recurrence rate at 12 months (OR = 1.69, 95%CI 0.95-2.49, p = 0.098). Maintenance of antiarrhythmic drugs after ablation was the only factor independently associated with a decreased risk of AF recurrence at 12 months (OR = 0.76, 95%CI 0.60-0.97, p = 0.046). CONCLUSION: This study suggests that the presence of an LCO or a RAPV is not associated with a higher rate of AF recurrence at 12 months after radiofrequency PVI using contact force-sensing catheters in PAF patients.
BACKGROUND: Pulmonary vein (PV) isolation (PVI) has become the cornerstone of atrial fibrillation (AF) ablation in patients with paroxysmal AF (PAF). PVI durability is influenced by many factors including PVs anatomy. Data regarding the influence of PVs anatomical variations on the outcomes of PAF ablation in the era of contact force-sensing ablation catheters are scarce and contradictory. METHODS: Consecutive patients referred to our center for a first ablation of PAF using radiofrequency (RF) were included. PVs anatomy was classified into 3 groups: typical anatomy (4 distinct veins), left common ostium (LCO), and right accessory PV (RAPV). The primary outcome was recurrence of atrial arrhythmia episode during a 12-month follow-up after ablation. RESULTS: Two hundred twenty-three patients were included (mean age 58.4 ± 10.8 years and 70.9% male). Among this cohort, 141 patients (63.2%) had typical PV anatomy, 53 (23.8%) had a LCO, and 29 (13.0%) had a RAPV. The existence of a RAPV was not associated with a higher rate of AF recurrences (22 (14.3%) vs. 7 (10.1%), p = 0.519). After multivariate analysis, the presence of an LCO did not appear to be associated with the AF recurrence rate at 12 months (OR = 1.69, 95%CI 0.95-2.49, p = 0.098). Maintenance of antiarrhythmic drugs after ablation was the only factor independently associated with a decreased risk of AF recurrence at 12 months (OR = 0.76, 95%CI 0.60-0.97, p = 0.046). CONCLUSION: This study suggests that the presence of an LCO or a RAPV is not associated with a higher rate of AF recurrence at 12 months after radiofrequency PVI using contact force-sensing catheters in PAF patients.
Authors: Petr Neuzil; Vivek Y Reddy; Josef Kautzner; Jan Petru; Dan Wichterle; Dipen Shah; Hendrik Lambert; Aude Yulzari; Erik Wissner; Karl-Heinz Kuck Journal: Circ Arrhythm Electrophysiol Date: 2013-03-20
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245
Authors: Atul Verma; Fethi Kilicaslan; Ennio Pisano; Nassir F Marrouche; Raffaele Fanelli; Johannes Brachmann; Jens Geunther; Domenico Potenza; David O Martin; Jennifer Cummings; J David Burkhardt; Walid Saliba; Robert A Schweikert; Andrea Natale Journal: Circulation Date: 2005-08-02 Impact factor: 29.690
Authors: Alex J A McLellan; Liang-han Ling; Diego Ruggiero; Michael C G Wong; Tomos E Walters; Ashley Nisbet; Anoop K Shetty; Sonia Azzopardi; Andrew J Taylor; Joseph B Morton; Jonathan M Kalman; Peter M Kistler Journal: Heart Rhythm Date: 2013-12-14 Impact factor: 6.343
Authors: Christian Sohns; Jan M Sohns; Leonard Bergau; Samuel Sossalla; Dirk Vollmann; Lars Lüthje; Wieland Staab; Marc Dorenkamp; James L Harrison; Mark D O'Neill; Joachim Lotz; Markus Zabel Journal: Europace Date: 2013-03-19 Impact factor: 5.214
Authors: Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins Journal: Eur Heart J Date: 2021-02-01 Impact factor: 29.983
Authors: Rafael M Ronsoni; Tiago L Silvestrini; Vidal Essebag; Renato D Lopes; Marco Aurélio Lumertz Saffi; Tiago Luiz Luz Leiria Journal: Indian Pacing Electrophysiol J Date: 2020-11-30